NMN and Common Medications: What You Actually Need to Know Before Starting

We wrote this article because we kept getting the same message in our inbox. Someone in their 50s or 60s, genuinely interested in what NMN could do for their energy, their sleep, their long-term health, and then a version of this: "I take three medications. Is this safe? My GP hasn't heard of it."

Most articles either ignore that question or answer it with a vague "consult a healthcare professional." We are going to actually answer it.

Medication	Examples	Risk	Action
Statins	Atorvastatin, Rosuvastatin, Simvastatin	Low	Niacin-statin concern does not apply to NMN. Disclose to GP.
Metformin	Glucophage, Metformin SR	Low	Potentially synergistic. Monitor blood glucose weeks 1-4.
Warfarin	Anticoagulant	Moderate	Speak to your anticoagulation clinic before starting.
DOACs	Apixaban, Rivaroxaban, Dabigatran	Low	Less sensitivity than warfarin. Disclose to GP.
Antidepressants	SSRIs, SNRIs	Low	Different systems. Take NMN in the morning. MAOIs: consult first.
Levothyroxine	Thyroid medication	Low	No pharmacological conflict. Separate doses by 4+ hours.
Blood pressure	ACE inhibitors, Beta blockers, CCBs	Low	No conflict. Monitor blood pressure in first 4 weeks.

 

The Short Answer

For most people on common medications, the direct pharmacological conflict risk with NMN is low. NMN is not processed through the cytochrome P450 enzyme system the way many pharmaceutical drugs are, which is where most significant drug interactions happen.

There are two areas of genuine caution: blood thinners (particularly warfarin), where a niacin-pathway connection creates a real monitoring consideration, and diabetes medications, where NMN's influence on insulin sensitivity creates a pharmacodynamic interaction worth knowing about.

Everything else in this guide falls into the category of worth knowing and worth mentioning to your GP, but not a reason to avoid NMN.

First, Let's Put the Niacin Confusion to Bed

Before we get into specific medications, we need to address something we see constantly in forums, comment sections, and yes, from some people who really should know better.

"Just take niacin instead of NMN. It does the same thing and it's a fraction of the price."

This claim is wrong, and it matters especially if you are taking medications, because the interaction profile of high-dose niacin and NMN are meaningfully different.

Here is the actual biology. Your body produces NAD+ through several pathways. The salvage pathway, which is the most important for adults, runs through an enzyme called NAMPT. Niacin (nicotinic acid) enters the Preiss-Handler pathway, a different and less efficient route that requires several additional enzymatic steps before it reaches NAD+. Nicotinamide (a different B3 form) enters via the salvage pathway but must be converted to NMN first by NAMPT, the very enzyme that becomes rate-limiting as we age.

NMN bypasses the NAMPT bottleneck entirely. It enters the cell and is converted directly to NAD+ in a single enzymatic step. This is not a marketing distinction. It is a fundamental difference in mechanism.

High-dose niacin also causes significant flushing, liver enzyme elevation at pharmacological doses, and documented interactions with statins and warfarin. NMN at standard supplementation doses (250-500mg) does not share these pharmacological behaviours. When your GP or pharmacist looks up niacin interactions and then warns you off NMN, they are applying the wrong data to the wrong molecule.

We have seen this frustration from our own customers repeatedly. People told by a well-meaning pharmacist that "it's just vitamin B3 in a different form, save your money." It is not just vitamin B3 in a different form. The pathway, the mechanism, the side-effect profile, and the interaction considerations are different. Understanding that distinction is exactly what this guide is for.

Medications at a Glance

Before diving into each category, here is a quick reference table. Full detail follows below.

Medication Type	Examples	Direct Interaction Risk	Key Consideration	Action
Statins	Atorvastatin, Rosuvastatin, Simvastatin	Low	Niacin-statin concern does not apply to NMN at standard doses	Disclose to GP; monitor if you have statin-related muscle pain
Metformin	Glucophage, Metformin SR	Low, potentially synergistic	Both activate NAD+/SIRT1 pathway via AMPK	Monitor blood glucose in first 4 weeks
Blood thinners	Warfarin	Moderate, monitor required	Niacin pathway can potentiate anticoagulant effect; NMN-specific data limited	Speak to GP or anticoagulation clinic before starting
Blood thinners	Apixaban, Rivaroxaban, Dabigatran	Low	DOACs have less dietary sensitivity than warfarin	Disclose to GP
Antidepressants	SSRIs, SNRIs	Low	Different biological systems; no direct serotonin interaction	Take NMN in morning; consult prescriber if on MAOIs
Thyroid medication	Levothyroxine	Low, timing only	Levothyroxine is absorption-sensitive; separate by 4+ hours	Simple timing solution
Blood pressure meds	ACE inhibitors, Beta blockers, CCBs	Low	Possible modest additive vascular benefit	Monitor blood pressure in first 4 weeks

Statins

Atorvastatin, rosuvastatin, simvastatin, pravastatin

The concern you may have encountered: high-dose niacin was historically combined with statins to raise HDL cholesterol. Later research found this combination did not reduce cardiovascular events and in some cases appeared to increase risk. Understandably, this made prescribers cautious about anything in the B3 family alongside statins.

What actually applies to NMN at supplement doses is quite different. The clinical trials running NMN at 250-500mg daily have not produced the lipid-disrupting or statin-interfering signals that emerged from gram-level niacin supplementation. They are not the same molecule operating on the same pathway.

There is actually a potentially useful positive consideration here. Statins reduce coenzyme Q10 (CoQ10) production in muscle tissue by inhibiting the mevalonate pathway, the same pathway used to produce cholesterol. This is the documented mechanism behind statin-associated muscle pain in a significant subset of patients. NMN supports mitochondrial energy production through the NAD+ pathway, not the mevalonate pathway, so it does not compound the CoQ10 depletion problem.

From our experience: A meaningful proportion of our customers who come to NMN are already on statins, often because they are in the exact age bracket where cardiovascular prevention is active. We have not had reports of adverse interactions. The most consistent feedback we hear is that the fatigue associated with statin use, which overlaps significantly with the fatigue of NAD+ decline, is what these customers are trying to address. 

Verdict: Low direct interaction concern at standard NMN doses. The legacy niacin-statin concern does not apply to NMN supplementation.

What to tell your GP: "I want to start NMN at 250-500mg daily alongside my statin. I understand the niacin-statin concern but NMN is metabolised differently and the clinical trials don't show the same signals. I'd like your view on whether there's anything to monitor."

Metformin

This is probably the most scientifically interesting interaction in this guide, because the relationship between metformin and NMN is not antagonistic. It is potentially synergistic, and the mechanism is worth understanding.

Metformin's primary blood sugar-lowering mechanism involves activating AMPK (AMP-activated protein kinase), an energy-sensing enzyme that regulates cellular metabolism. This AMPK activation feeds into the same NAD+/sirtuin pathway that NMN supports. Research published in Signal Transduction and Targeted Therapy (2022) showed that metformin inhibits a microRNA called miR-146a, which normally suppresses NAMPT, the rate-limiting enzyme in NAD+ production.

By releasing this suppression, metformin indirectly boosts NAD+ production through one mechanism. NMN supplementation converges on the same outcome through a different upstream route.

These two interventions are working towards the same biological goal, not competing with each other.

The consideration worth knowing about: NMN has demonstrated improvements in insulin sensitivity in human trials. A randomised controlled trial in postmenopausal women with prediabetes showed meaningful insulin sensitivity improvement from NMN supplementation. If you are taking metformin to manage blood sugar, adding something that independently improves insulin sensitivity means the overall glucose effect could be greater than from either alone. This is not dangerous in itself, but blood glucose monitoring in the first four weeks is the sensible response.

It is also worth noting that a 2025 systematic review and meta-analysis covering eight randomised controlled trials found no significant effect of NMN on fasting glucose or glycated haemoglobin in non-diabetic and prediabetic adults at doses up to 2000mg. The insulin-sensitising effect appears real but moderate in healthy populations, which is reassuring context.

Verdict: No direct pharmacological conflict. Possible additive effect on insulin sensitivity worth monitoring. The underlying biology is supportive rather than conflicting.

What to tell your GP: "I want to try NMN at 250-500mg daily. I know it may have some independent effect on insulin sensitivity. I'd like to monitor blood glucose a bit more closely in the first month to see if there's any change in how my metformin is working."

Blood Thinners

Warfarin

This is the area of greatest genuine caution in this entire guide. We are going to be direct with you.

A published case report in the pharmacological literature documented a significantly elevated INR in a patient on warfarin following an increase in extended-release niacin dose. The proposed mechanism involves niacin's metabolic pathway creating a synergistic coagulopathy that amplifies warfarin's anticoagulant effect.

NMN is not high-dose niacin. The direct evidence for a problem with NMN specifically is absent. But the evidence base for NMN alongside warfarin is also essentially absent. There are no published human studies directly testing this combination. And warfarin has an unusually narrow therapeutic window, meaning even modest pharmacokinetic changes can shift INR into a range that increases bleeding or clotting risk.

Our position on this one: do not start NMN alongside warfarin without first speaking to your GP or anticoagulation clinic. That is a firm recommendation from us, not a liability disclaimer. The theoretical pathway is real enough and the stakes are high enough that the conversation is worth having before you start rather than after something changes.

What to tell your anticoagulation clinic: "I'd like to start NMN, an NAD+ precursor supplement. I know there's a documented case report of niacin interacting with warfarin via INR elevation. NMN is metabolised differently but specific human data on NMN and warfarin is limited. Can we discuss whether to monitor INR more frequently when I start?"

Direct Oral Anticoagulants (apixaban, rivaroxaban, dabigatran)

The concern here is lower. DOACs do not require the same level of dietary and supplement monitoring as warfarin, and the niacin-warfarin interaction mechanism is less applicable to this drug class. Disclosure to your GP or prescriber is still sensible, but this sits in the "inform rather than seek permission" category for most people.

Antidepressants and Anxiolytics

SSRIs, SNRIs, benzodiazepines

NAD+ plays a documented role in neurological function, particularly through the SIRT1 deacetylase pathway, which has downstream effects on neuroinflammation, mitochondrial health in brain tissue, and circadian rhythm regulation. This is partly why there is genuine research interest in NMN for neurodegenerative and mood-adjacent conditions.

The direct pharmacological interaction concern with SSRIs and SNRIs is low. These medications act on serotonin and noradrenaline reuptake transporters. NMN does not directly interfere with serotonin metabolism or receptor binding at standard supplement doses. They operate on different biological systems.

The practical nuance: NMN commonly improves energy, alertness, and sleep quality. If you are on a sedating medication (certain tricyclics, mirtazapine, or benzodiazepines for anxiety), taking NMN in the morning rather than evening is the straightforward solution. This is already the recommended timing for NMN regardless, and it avoids any potential for the energising effect to work against a medication you are taking specifically to help you calm down or sleep.

For MAOIs (monoamine oxidase inhibitors, an older antidepressant class less commonly prescribed today): MAOIs interact with a very broad range of compounds and the interaction landscape is complex enough that we would not offer a general reassurance here. Please check with your prescribing psychiatrist before adding any supplement.

Verdict: Low direct pharmacological concern for SSRIs and SNRIs. Morning dosing is the practical answer for sedating medication users. MAOI users need a specialist conversation.

Thyroid Medication (Levothyroxine)

Hypothyroidism is extremely common in the 50+ population, particularly in women, making levothyroxine one of the most widely prescribed medications in the UK. This is a question we get regularly from our customer base.

The honest answer is that there is no meaningful pharmacological interaction between NMN and levothyroxine. They operate on entirely different systems. A human NMN trial specifically checked TSH and thyroid hormone levels and found no significant changes, which is direct reassurance for anyone concerned that NMN might disrupt thyroid function.

The practical consideration is absorption timing. Levothyroxine is notoriously sensitive to absorption interference. It needs to be taken on an empty stomach and separated from calcium, iron, magnesium, fibre, and most supplements by at least four hours. NMN is not in the category of compounds known to bind to levothyroxine. But because levothyroxine's absorption is so easily disrupted, the clean solution is simply to take NMN at a completely different time of day.

What we suggest: Take levothyroxine as usual on an empty stomach first thing in the morning. Take NMN with breakfast or mid-morning. No pharmacological conflict, no absorption interference, no medication adjustment needed.

Verdict: No pharmacological interaction concern. Timing solves everything.

Blood Pressure Medications

ACE inhibitors, beta blockers, calcium channel blockers, diuretics

NMN does not directly affect blood pressure through a mechanism expected to conflict with antihypertensive medications.

The more interesting consideration here is that NMN may actually be modestly complementary. A 2023 study found that NMN supplementation in hypertensive patients partially restored NAD+ levels in peripheral blood mononuclear cells alongside lifestyle changes, suggesting a positive rather than conflicting relationship with vascular function.

If NMN does have a modest blood pressure-supporting effect and you are already on antihypertensive medication, monitoring blood pressure during the first few weeks of supplementation is sensible so you have a clear picture. This is straightforward for anyone who already takes home readings, which many patients on blood pressure medication do.

Verdict: No direct pharmacological conflict. Possible additive vascular benefit worth monitoring if your blood pressure is tightly managed.

A Practical GP Conversation Guide

"Talk to your doctor" is advice that only works if you can walk in with something useful to say. Most GPs will not have NMN-specific knowledge. The research is moving faster than most primary care curricula, and that is not a criticism of GPs. Here is a template you can adapt.

Opening: "I'm interested in starting NMN, which is an NAD+ precursor supplement, at a dose of 250-500mg per day. I've been researching it for general longevity and energy support."

If drug interaction databases come up: "I understand pharmacies may flag niacin interactions when they search for NMN. NMN is metabolised differently to pharmacological doses of niacin and the concern from high-dose niacin research doesn't straightforwardly apply. The specific consideration for my medication is [use the relevant section above]."

Ask a direct question: "Would you want to monitor anything specific when I start? And is there a timing consideration I should know about for taking this alongside my [medication name]?"

State what you will track: "I'm happy to monitor [blood glucose / blood pressure / INR] more frequently in the first four weeks so we have a clear picture."

Most of these conversations will be brief and reassuring. The purpose is disclosure and shared decision-making, not seeking permission for something dangerous.

What We Still Do Not Know

We are going to be honest about the gaps in the evidence rather than project false confidence.

There are no published randomised controlled trials specifically designed to test NMN alongside any of the medications in this guide. What we have is a combination of: mechanistic understanding of how NMN is metabolised, indirect evidence from niacin and nicotinamide research (with the important caveat that they are different molecules), the absence of reported interactions in human NMN trials to date, and a growing real-world safety record from supplementation.

The people most likely to be taking multiple medications are often the least represented in supplementation research. Trials typically exclude patients on complex medication regimens. This is a genuine limitation in the evidence base and we are not going to pretend otherwise.

The Bottom Line

Most people on the common medications above can take NMN at standard doses without meaningful pharmacological conflict. The areas requiring the most care are warfarin (speak to your anticoagulation clinic before starting) and diabetes medications (monitor blood glucose in the first month). Everything else comes down to sensible timing and disclosure.

The longer-term picture is also worth stating directly. NAD+ decline is a real and well-documented feature of ageing. The conditions that bring most people to the medications in this guide (cardiovascular disease, metabolic conditions, hypothyroidism) are precisely the conditions where mitochondrial health and cellular energy production are most relevant. T

he case for NMN supporting rather than conflicting with the management of these conditions is scientifically coherent, even where the direct human evidence for specific drug combinations remains limited.

Take this guide to your GP. Have an honest conversation. You may find yourself doing some of the explaining, which is exactly why we wrote this.

Further reading:

• How NMN works in the body
• Why NMN, niacin, and NR are not interchangeable
• NMN dosage guide: how much to take and when

Last reviewed: April 2026. We update this article as new human trial data becomes available.

Disclosure: we are a supplement company, not a medical practice. Nothing here replaces your prescribing doctor's advice. What we can offer is a genuinely thorough, evidence-referenced starting point so that the conversation with your GP is an informed one rather than a confused one.